Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a global information technology, consulting and business process services company, has announced that it has been named a provider of IDC MarketScape: Worldwide Life Science Drug Safety Services, 2019–2020 Vendor Assessment — Building for Innovation (Doc # US45863116, January 2020)IDC MarketScape.
The report mentions that “Relative to other vendors discussed in this document and based on feedback from multiple customer references, Wipro received high marks for its solid delivery capabilities, rapid onboarding, ability to deliver high value for money, and significant commitment to investing in innovation in the Drug Safety Services (DSS) space.”
Highlighting Wipro´s capabilities, the report mentions “Wipro´s approach to DSS Centre of Excellence is multifaceted, with groups focused on optimizing DSS client engagement, Pharmacovigilance (PV) process transformation leveraging cognitive automation, and PV quality and process excellence. This approach is very well aligned with industry and sponsor needs, and Wipro is already beginning to gain success in its innovation and transformation initiatives.”
IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
Wipro Limited is a global information technology, consulting and business process services company.